Crenessity: Cost, dosage, side effects, uses, interactions, and more

What is Crenessity?

Crenessity is a prescription medicine used together with glucocorticoid replacement (your steroid/cortisol
replacement therapy) to help control androgen (testosterone-like hormone) levels in people with
classic congenital adrenal hyperplasia.

It’s approved for adults and pediatric patients ages 4 years and older. It comes as oral capsules and an oral solution.
In plain English: it’s meant to be an add-on therapy, not a replacement for your baseline glucocorticoids.

Quick CAH refresher: Why androgens are the troublemakers

In classic CAH (often due to 21-hydroxylase deficiency), the adrenal glands can’t make enough cortisol. The body tries to fix this
by turning up hormonal signals upstream, which can lead to overproduction of adrenal androgens. Clinically, excess androgens may
contribute to issues like acne, hirsutism, menstrual irregularities, advanced bone age, growth problems, and fertility challenges.

Standard treatment includes glucocorticoids to replace cortisol and suppress excess androgen production. But here’s the catch:
doses high enough to suppress androgens can be higher than what’s needed for cortisol replacement aloneand long-term higher steroid
exposure can come with real downsides (weight gain, metabolic effects, bone health concerns, mood changes, and more).

Crenessity enters the chat to help reduce excess adrenal androgen production so some people may be able to use
lower glucocorticoid doses while maintaining androgen control. (Yes, endocrine care can be a game of “lower the dose… but not too low.”)

How Crenessity works (mechanism of action)

Crenessity is a corticotropin-releasing factor type 1 (CRF1) receptor antagonist. Think of CRF as part of the upstream
“alarm system” that tells your body to produce ACTH (adrenocorticotropic hormone), which then signals the adrenal glands.
In classic CAH, that signal pathway can contribute to excess androgen production.

By blocking CRF1 receptors, Crenessity can help lower the drive that contributes to adrenal androgen overproduction. The goal isn’t to
“turn hormones off,” but to help bring the system closer to a controlled rangeideally allowing steroid doses to move toward
replacement-level dosing where appropriate.

Approved uses

Indication: Crenessity is indicated as an adjunctive treatment to glucocorticoid replacement to control
androgens in adults and children ages 4+ with classic CAH.

What Crenessity is not

• Not a rescue medication for adrenal crisis.
• Not a substitute for glucocorticoid replacement.
• Not a “DIY dose-lowering permission slip” for steroids. Dose adjustments must be guided by your clinician.

Clinical trial snapshot: What benefits were seen?

FDA approval was based on two randomized, double-blind, placebo-controlled trials in adults and children with classic CAH.
In adults, people taking Crenessity were able to reduce their total daily glucocorticoid dose while maintaining control of
androstenedione (a key androgen marker). In the pediatric trial, Crenessity improved androstenedione levels and also allowed
glucocorticoid dose reductions while maintaining control.

The headline takeaway: Crenessity is intended to help control androgen levels and may support clinically guided steroid dose reductions
in appropriately selected patientswhile continuing replacement therapy for adrenal insufficiency.

Dosage and how to take Crenessity

Crenessity is taken by mouth twice dailytypically once with a morning meal and once with an evening meal.
“With a meal” matters here, and the prescribing information notes it can be taken with a meal regardless of fat or caloric content.

Adult dosage (typical)

• Adults: 100 mg orally twice daily with a meal (morning and evening).

Pediatric dosage (ages 4+): weight-based

Typical dosing is twice daily with a meal:

Dosage forms and strengths

• Capsules: 25 mg, 50 mg, 100 mg
• Oral solution: 50 mg/mL

Missed dose basics

If you miss a dose, general label guidance is to take a dose as soon as possible (even if it’s close to the next scheduled dose),
then resume your regular schedule. If you’re unsureor if you’ve missed multiple dosescontact your care team for personalized direction.

Important: Steroids still matter (a lot)

Crenessity is used with glucocorticoids. Patients should continue glucocorticoid replacement for adrenal insufficiency.
Your clinician may check androstenedione levels after you’ve been on Crenessity for a bit (often around the first month) to help guide
any steroid dose reductions. The goal is to avoid dropping below what’s needed for cortisol replacement.

How to take it in real life (practical tips)

• Pair it with predictable meals: breakfast + dinner is usually easiest.
• Use reminders: two daily doses can be “set it and forget it”… until you forget it. Phone alarms help.
• Swallow capsules whole with liquid unless your pharmacist/prescriber instructs otherwise.
• Oral solution: measure carefully using the device provided by the pharmacy; discard unused solution after the recommended period after opening.

Drug interactions

Crenessity is metabolized through pathways involving CYP3A4. Translation: certain medications and supplements can change
how much Crenessity is in your body.

Big one: CYP3A4 inducers (can lower Crenessity exposure)

Strong or moderate CYP3A4 inducers can reduce crinecerfont exposure, which may reduce effectiveness. The prescribing information
includes dose adjustment guidance (your prescriber will handle this, but it’s useful to know it’s a thing).

Examples of CYP3A4 inducers (not a complete list)

• Strong inducers: rifampin, carbamazepine, phenytoin, St. John’s wort
• Moderate inducers: examples vary; your pharmacist can confirm whether one of your meds falls in this category

What about CYP3A4 inhibitors?

Strong CYP3A4 inhibitors (for example, ketoconazole) can increase crinecerfont exposure. That doesn’t automatically mean “never use together,”
but it does mean your care team may monitor you more closely for side effects or adjust therapy choices.

Medication list rule (the boring rule that saves lives)

Bring a full medication list to appointmentsincluding OTC meds, supplements, and herbs. If a clinician asks,
“Any supplements?” and you say “No,” while St. John’s wort hides in your cabinet like a cartoon villain… that’s how interactions happen.

Side effects

Side effects vary by person, and trials report rates under controlled conditionsmeaning the “real world” can feel different.
Still, knowing what’s common (and what’s urgent) helps you plan.

Most common side effects in adults

• Fatigue/tiredness
• Headache
• Dizziness
• Joint pain (arthralgia)
• Back pain
• Decreased appetite
• Muscle pain (myalgia)

Most common side effects in children (ages 4+)

• Headache
• Abdominal (stomach) pain
• Fatigue/tiredness
• Nasal congestion
• Nosebleeds (epistaxis)

Serious risks and warnings to know

1) Hypersensitivity reactions (allergic-type reactions)

Crenessity is contraindicated in people with hypersensitivity to crinecerfont or any components.
Reactions reported include throat tightness, angioedema, and generalized rash. If you notice symptoms of a serious allergic reaction,
seek medical attention right away.

2) Risk of acute adrenal insufficiency or adrenal crisis if glucocorticoids are inadequate

This is the most important “don’t skim this” part. Patients taking Crenessity should continue glucocorticoids.
If glucocorticoid dosing becomes inadequateespecially during times when the body needs more cortisol (illness, injury, surgery)acute
adrenal insufficiency or adrenal crisis can occur and may be life-threatening.

If you have symptoms like extreme weakness, dizziness/fainting, severe nausea/vomiting, confusion, or a fast heart rateespecially during illnesstreat it as urgent.
Follow your care plan for stress dosing and emergency injection, and seek emergency care as directed by your clinician.

3) Mood and suicidal ideation monitoring (especially in pediatric patients)

In the pediatric trial, suicidal ideation without method/intent/plan was reported in a subset of participants receiving Crenessity,
and none in the placebo group during the double-blind period (with important trial exclusions for active ideation/behavior).
This doesn’t mean Crenessity “causes” suicidal thoughts in every patient, but it does mean mental health symptoms should be taken seriously.

If you or your child experiences new or worsening mood symptoms, anxiety, depression, or any suicidal thoughts, contact your healthcare provider immediately.
If danger is imminent, call 911 (or your local emergency number).

4) Lab changes: neutrophil counts

The prescribing information reports decreases in neutrophil counts in clinical trials. Your clinician may monitor labs as appropriate,
especially if you have other reasons to watch blood counts.

Who should not take Crenessity?

• Anyone with hypersensitivity to crinecerfont or any ingredient in the product.

Precautions and special populations

• Severe renal impairment/end-stage renal disease: Crenessity is not recommended in severe renal impairment or ESRD (per prescribing information).
• Pregnancy: Human pregnancy data are limited. Discuss risks and benefits with your prescriber; pregnancy safety monitoring programs may exist.
• Breastfeeding: Talk with your clinician about the benefits of breastfeeding and the potential risks of exposure.
• Mental health history: Share any history of depression, anxiety, or suicidal thoughtsespecially when starting a new therapy.

Cost in the U.S. and access realities

Let’s talk about the elephant in the pharmacy: price. Specialty drugs can carry very high list prices, and Crenessity is no exception.
Public company disclosures reported a U.S. wholesale acquisition cost (WAC) of roughly $38,333 for a 30-day supply for adults and about
$19,167 for a 30-day supply for pediatric patients under 20 kg (list-price context). Your actual out-of-pocket cost depends heavily on insurance.

Why your cost may be very different from the list price

• Insurance coverage: Many plans require prior authorization for specialty medications.
• Copay assistance: Manufacturer programs may reduce copays for commercially insured patients (eligibility rules apply).
• Patient assistance programs: Options may exist for people without coverage or with financial hardship.
• Specialty pharmacy distribution: Some drugs are handled through specialty pharmacies, which can affect logistics and billing.

Practical ways patients often reduce out-of-pocket costs

1. Ask about prior authorization support: Your prescriber’s office and support hubs can often help with paperwork.
2. Request a benefits investigation: This clarifies what your plan covers before you’re stuck playing phone-tag with your insurer.
3. Explore copay cards (commercial insurance): If eligible, these can be a big help.
4. If denied, appeal: Many denials are “administrative first drafts,” not final answers.
5. Keep documentation: Diagnosis details, labs (like androstenedione), and treatment history can support coverage decisions.

Bottom line: cost is often less about the sticker price and more about navigating coverage. It’s annoying, but it’s navigableand you shouldn’t have to do it alone.

Common questions (FAQ)

Is Crenessity a steroid?

No. Crenessity is not a glucocorticoid. It’s used alongside steroid replacement therapy to help control androgen levels in classic CAH.

How long does it take to work?

Response is individual. Clinicians may assess hormone markers such as androstenedione after the first several weeks to help guide steroid dose adjustments.
Your symptoms and lab trends together tell the story.

Do I still need a stress-dose plan?

Yes. Anyone with adrenal insufficiency needs a stress-dose plan for illness, injury, or surgery, whether they take Crenessity or not.
Crenessity does not replace that safety net.

Can Crenessity help lower my steroid dose?

That’s one of its goalsunder clinician supervision. Trial results supported reductions in glucocorticoid dosing while maintaining androgen control in many participants,
but dosing decisions must be individualized.

Real-world experiences (what patients and caregivers often report)

Because Crenessity is relatively new, “real-world experience” is still emerging. But even early on, certain themes are common in specialty-drug journeys for rare
endocrine conditionsespecially when a medication is added to an already complex routine. The experiences below are
illustrative composites based on patterns that clinicians, patient advocates, and families commonly discuss (not one person’s story).

1) The “two meals a day” habit is the real MVP

Many adults say the simplest win is pairing doses with a consistent breakfast and dinner. People who previously skipped breakfast often end up doing a “mini breakfast”
(yogurt, toast, smoothie) so the morning dose stays predictable. It’s not glamorous, but it’s effective. Families of kids with CAH frequently build Crenessity into
school-day routines: breakfast at home, dinner after practice, and a backup reminder on a caregiver’s phone in case life gets chaotic.

2) Early side effects can feel like “Is this the med… or is this Tuesday?”

Fatigue and headaches are commonly mentioned, and patients sometimes describe the first couple of weeks as a period of “background noise” symptomsmild tiredness,
occasional dizziness, or reduced appetite. The tricky part is that CAH itself, sleep, stress, and steroid adjustments can all affect energy and mood. People often find
it helpful to track symptoms briefly (a simple notes app works) so they can share patterns with their endocrinology team instead of trying to remember everything
during a 12-minute appointment.

3) The steroid conversation becomes more data-driven

Patients often report that starting Crenessity makes lab timing and symptom journaling feel more relevantbecause dose adjustments can be on the table.
A common experience is a structured plan: “We’ll check androstenedione after a few weeks, then slowly step down steroidsno rushing.” People who have lived through
the consequences of over-suppression (Cushingoid effects, weight changes, mood swings) may feel cautiously hopeful. People who have experienced under-replacement
(lightheadedness, nausea during illness, scary ER trips) tend to be appropriately cautiousbecause adrenal crisis risk is never an abstract concept for them.

4) Insurance logistics: the paperwork arc is real

Families frequently describe access as a two-step story: medical decision first, then coverage reality. Prior authorization can take time, and it’s common to hear
about multiple phone calls, benefit investigations, and “Where is the form?” moments. The families who feel most supported often have a point person (clinic nurse,
specialty pharmacy coordinator, or support hub representative) who can translate insurer language into something human. The advice that comes up again and again:
keep copies of everything, document dates, and don’t be afraid to appeal a denial.

5) Mental health check-ins become part of responsible care

Some caregivers appreciate that starting a new medication is a good reason to normalize mental health screeningespecially for adolescents already navigating puberty,
body changes, and chronic illness stress. Rather than treating mood conversations as “extra,” many families build them into routine check-ins:
“How’s your sleep? Any new anxiety? Feeling down more days than not?” It’s not about panicit’s about catching problems early.

The big picture from these shared themes: people do best when Crenessity is treated as part of a complete care planlabs, symptom tracking, stress-dose preparedness,
and practical support for access. The medication may change the balance, but the safety fundamentals stay the same.